Related references
Note: Only part of the references are listed.Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
Carlos Aya-Bonilla et al.
CANCERS (2019)
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
Leslie Calapre et al.
MOLECULAR ONCOLOGY (2019)
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Ashleigh C. McEvoy et al.
BMC CANCER (2018)
Melanoma circulating tumor cells: Benefits and challenges required for clinical application
G. Marsavela et al.
CANCER LETTERS (2018)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization
Masahiko Yanagita et al.
MELANOMA RESEARCH (2018)
Emergencies in the Treatment of Wandering Spleen
Osher Cohen et al.
ISRAEL MEDICAL ASSOCIATION JOURNAL (2018)
Harnessing Tumor Evolution to Circumvent Resistance
Katherine L. Pogrebniak et al.
TRENDS IN GENETICS (2018)
82PPD-L1 expression on pre-treatment circulating tumour cells, but not serum VEGF, is predictive of response to pembrolizumab in melanoma
M A Khattak et al.
ANNALS OF ONCOLOGY (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
Xin Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma
Ashleigh C. McEvoy et al.
ONCOTARGET (2017)
Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device
Carlos A. Aya-Bonilla et al.
Oncotarget (2017)
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
Clemens Krepler et al.
CELL REPORTS (2017)
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma
J. H. Lee et al.
ANNALS OF ONCOLOGY (2017)
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer
Jakub Chudziak et al.
ANALYST (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
Maria Romina Girotti et al.
CANCER CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
Anna L. Reid et al.
CLINICAL BIOCHEMISTRY (2015)
Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment
Elin S. Gray et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
Dragana Klinac et al.
BMC CANCER (2014)
ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Brian J. Wilson et al.
CANCER RESEARCH (2014)
Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma
Leila Khoja et al.
MELANOMA RESEARCH (2014)
Isolation and Molecular Characterization of Circulating Melanoma Cells
Xi Luo et al.
CELL REPORTS (2014)
Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma
Leila Khoja et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Melanoma Cell Invasiveness Is Promoted at Least in Part by the Epidermal Growth Factor-Like Repeats of Tenascin-C
Jelena Grahovac et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
Emre Ozkumur et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
James B. Freeman et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
Daniel Ramskold et al.
NATURE BIOTECHNOLOGY (2012)
RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells
Verena Kupas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)
Sandra Medic et al.
PLOS ONE (2010)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
Pax3 functions at a nodal point in melanocyte stem cell differentiation
D Lang et al.
NATURE (2005)
The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: Link between melanin synthesis and melanosome biogenesis
F Vetrini et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)